LGM
BNTX icon

Logos Global Management’s BioNTech BNTX Stock Holding History

Logos Global Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200,000
Closed -$18.2M – 53
2025
Q1 		$18.2M Sell
200,000
-100,000
-33% -$11.2M 3.24% 10
2024
Q4 		$34.2M Buy
+300,000
New +$34.2M 4% 6
2020
Q3 		– Sell
-295,000
Closed -$19.7M – 49
2020
Q2 		$19.7M Buy
+295,000
New +$14.7M 3.93% 6

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Logos Global Management's BNTX Position: Q2 2025 in Review

Logos Global Management sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 200,000 shares — an estimated $18.2M sold.

Logos Global Management first reported a position in BNTX in Q2 2020 and held it in 3 quarters. The position peaked at $34.2M in Q4 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Logos Global Management reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Logos Global Management sold 200,000 BioNTech shares in Q2 2025, an estimated $18.2M.
  • Logos Global Management first reported a position in BioNTech in Q2 2020 and held it in 3 quarters.
  • Logos Global Management's BioNTech position peaked at $34.2M in Q4 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Logos Global Management's 13F filing for Q2 2025, filed 14 Aug 2025.